Document Classification

Section Type: RESULTS

Text: Patients in group B (treated with ciprofibrate) compared with group A (control) had significantly higher reductions in total cholesterol (downward arrow 14. 2 % vs. downward arrow 4. 8 % ; P < 0. 02), triglycerides (downward arrow 38. 0 % vs. downward arrow 21. 6 % ; P < 0. 007), very low density lipoprotein cholesterol (downward arrow 38. 0 % vs. downward arrow 21. 6 % ; P < 0. 007), non-HDL cholesterol (downward arrow 20. 5 % vs. downward arrow 7. 1 % ; P < 0. 007), and total cholesterol/high density cholesterol ratio (downward arrow 25. 6 % vs. downward arrow 9. 4 % ; P < 0. 01).